Bio:Dr Shaked is the CEO of Biorap Technologies – the technology transfer unit of the Rappaport Family Institute for Research in the Medical Sciences. Dr Shaked is responsible for providing Rappaport Institute scientists with assistance in business development, strategic alliance development, identification of investors, establishment of startups, and other areas associated with commercialization of medical technologies. In addition, Biorap Technologies is responsible for managing the Genomic Core Facility which provides top tier genomic technologies to universities, hospitals and biopharma companies. Until 2010 Dr. Orit Shaked was the Chief Technology Officer and Business Development at Meytav Technological Incubator. Prior to joining Meytav, Dr. Shaked served as the Director of Product ID and Portfolio management at Teva Pharmaceuticals, specializing in Biosimilar and Hospital franchises (Autoimmune diseases, Oncology, Endocrinology and Wound healing). She was responsible for project analysis, market opportunities evaluation and launch of the first Bio-similar product. Dr. Shaked was also the Managing Director of UBT Medical. She also held several research and development and business development positions in bio start-ups. Dr. Shaked is a Director of Turboseal Ltd. She holds a Ph.D. in Medical Sciences and an M.B.A. from the Technion – Israel institute of Technology